Tempus AI TEM jumped 7.3% at yesterday’s close after securing FDA 510(k) clearance for its ECG-Low EF software, its second greenlighted AI tool in cardiology. The approval adds fuel to a stock already ...
At the Stanford Energy Seminar on Monday, Breakthrough Energy Ventures partner Libby Wayman highlighted soaring electricity ...
Discover how rapid AI advances could trigger an AGI-driven market bubble by 2026, reshape equities, and impact rates.
MELBOURNE, Fla., June 5, 2025 /PRNewswire/ -- Maritime Tactical Systems, Inc. (MARTAC), America's leader in fully autonomous maritime surface vessels, today hosted its first-ever Investor Day at its ...
Growth investment will help the company build new manufacturing partnerships, drive talent acquisition, and strengthen product capabilities SAN DIEGO & CANBERRA, Australia--(BUSINESS WIRE)--Liquid ...
IonQ's third-quarter revenue came in much higher than management had previously predicted. Over the last year, IonQ has spent billions of dollars acquiring competing quantum AI businesses. For now, ...
Palo Alto Investors LP disclosed in its SEC filing dated November 14 that it increased its holding in Dyne Therapeutics ( DYN 1.08%) by 997,698 shares during the third quarter. The post-trade position ...
With momentum surging across diagnostics, data, and Artificial Intelligence (AI), Tempus AI is fast becoming a precision medicine powerhouse. For investors, now’s the time to gauge just how big this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback